COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Intravitreal Sirolimus as Therapeutic Approach to Uveitis (SAVE-2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01280669
Recruitment Status : Recruiting
First Posted : January 21, 2011
Last Update Posted : March 17, 2020
Santen Inc.
Information provided by (Responsible Party):
Quan Dong Nguyen, Stanford University

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 2021
Estimated Study Completion Date : December 2021